Healthcare encounters (2016 encounters) with interventions for diagnosing, treating and monitoring adverse drug events (ADEs), and the resulting direct costs per encounter.

* The cost of the intervention included in the direct costs caused by ADEs. Excluding encounters, and costs for interventions not identified in registers.
†Prescribing of drugs associated with abuse or dependence were not analysed according to care level, since prescriber data was not available in the Swedish Prescribed Drug Register.
‡In addition, two individuals were prescribed medicines (total cost: USD 140.6) for treating ADEs during healthcare encounters that were not identified in the Cost Per Patient Register.

* 本研究纳入的干预成本涵盖由不良药物事件（Adverse Drug Event, ADE）引发的直接成本，排除就诊相关费用以及登记系统未收录的干预成本。
† 鉴于瑞典处方药登记册（Swedish Prescribed Drug Register）未留存处方医师相关数据，故未按照医疗照护层级对与药物滥用或依赖相关的处方行为开展分析。
‡ 另有2名患者在每患者成本登记册（Cost Per Patient Register）未记录的诊疗过程中接受了针对不良药物事件的药物治疗，总费用为140.6美元。